By: Lana Pine
At Week 52, icotrokinra achieved clear/almost clear skin in 72% of patients with scalp psoriasis and 85% with genital psoriasis, with consistent safety and durable responses.
Lana Pine
Geo Focus
Coverage Attributes:
Beta
Informative:
41
%
Data Driven:
25
%
Interviews Q&as:
20
%
Promotional:
8
%
Product Service Comparisons:
4
%
Themes Covered:
Not enough data
Pitching Insights
Lana Pine's coverage primarily focuses on healthcare and pharmaceutical topics, particularly pertaining to conditions such as gout, rheumatoid arthritis, fibromyalgia, and biosimilars. Her articles frequently cite data and include expert commentary.
Given Lana's focus on these specific medical conditions and treatments, she would likely be interested in hearing from experts who can provide insights into the latest research findings or clinical developments related to these areas. This could include researchers with access to new data or those at the forefront of innovative treatments.
While Lana does not specify a geographic focus, her coverage appears to take an international perspective on healthcare issues without being limited by location. Therefore, relevant experts from any region may find their insights valuable for her audience.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
